Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Danish Court Stops Sale of Generic Lipitor | Contract Pharma

What are you searching for?

Sign in
Breaking News

Danish Court Stops Sale of Generic Lipitor

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

A Danish court has granted a preliminary injunction against Nomeco A/S, a pharmaceutical wholesaler in Denmark, prohibiting the sale of a generic version of Pfizer’s Lipitor by Ranbaxy. The injunction, issued by the Copenhagen City Court in Denmark and subject to appeal by Nomeco, requires Ranbaxy’s generic atorvastatin product to be withdrawn from the Danish market pending the outcome of a patent infringement trial that has not yet been scheduled.

The court ruled in Pfizer’s favor on the three patents, atorvastatin calcium, the active ingredient in Lipitor, as well as processes and intermediate compounds used to make atorvastatin. The latest expiring patent provides coverage for Lipitor through November 2011.

“This ruling is another significant milestone in our defense of Lipitor patents around the world,” said Pfizer’s senior vice president and general counsel Allen Waxman. “And it’s an important outcome for Pfizer and other medical innovators who invest in high-risk research to develop life-saving medicines for millions of patients,” added Karin Verland, country manager of Pfizer Denmark.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters